methylprednisolone aceponate has been researched along with clobetasol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Jahn, P; Kecskés, A; Lange, L | 1 |
| Jahn, P; Kecskés, A; Kuhlmann, RK; Lange, L; Matthes, H | 1 |
| Kyriakou, A; Patsatsi, A; Patsialas, C; Sotiriadis, D | 1 |
| Cordoba-Guijarro, S; Fernández-Redondo, V; García-Doval, I; Gatica-Ortega, ME; Giménez-Arnau, A; González-Pérez, R; Mercader-García, P; Pastor-Nieto, MA; Serra-Baldrich, E; Silvestre-Salvador, JF | 1 |
| Bradford, J; Chin, S; Fischer, G; Lee, G; Scurry, J | 1 |
2 trial(s) available for methylprednisolone aceponate and clobetasol
| Article | Year |
|---|---|
Local tolerability of topically applied methylprednisolone aceponate.
Topics: Administration, Cutaneous; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Atrophy; Betamethasone Valerate; Clobetasol; Dermatitis, Phototoxic; Double-Blind Method; Drug Tolerance; Female; Humans; Irritants; Male; Methylprednisolone; Occlusive Dressings; Ointments; Prednisolone; Skin; Skin Tests | 1993 |
Systemic effects of topically applied methylprednisolone aceponate in healthy volunteers.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Topical; Adrenal Glands; Adult; Anti-Inflammatory Agents; Betamethasone Valerate; Circadian Rhythm; Clobetasol; Drug Tolerance; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Occlusive Dressings; Ointments; Time Factors | 1993 |
4 other study(ies) available for methylprednisolone aceponate and clobetasol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Treatment of male genital lichen sclerosus with clobetasol propionate and maintenance with either methylprednisolone aceponate or tacrolimus: a retrospective study.
Topics: Adult; Clobetasol; Genital Diseases, Male; Humans; Lichen Sclerosus et Atrophicus; Maintenance Chemotherapy; Male; Methylprednisolone; Pruritus; Quality of Life; Retrospective Studies; Secondary Prevention; Skin Cream; Tacrolimus | 2013 |
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
Topics: Administration, Cutaneous; Adult; Betamethasone; Betamethasone Valerate; Clobetasol; Dermatitis, Allergic Contact; Dermatologic Agents; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Mometasone Furoate; Patch Tests; Predictive Value of Tests; Prednisolone; Prevalence; Prospective Studies; Spain | 2018 |
Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Carcinoma in Situ; Carcinoma, Squamous Cell; Clobetasol; Desonide; Female; Humans; Hydrocortisone; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Vulvar Lichen Sclerosus; Vulvar Neoplasms | 2020 |